Home
About Us
Resources
News & Events
Sites
Product Search
Careers
Contact
EN
/
中文
Discovery
Overview & Highlights
Key Capabilities
Key Capabilities
Building Blocks
Synthetic Chemistry
Discovery Platforms
Discovery Platforms
Virtual Screening
DELT
FBDD
Teams & Experience
Facilities
Development & Manufacturing
Overview & Highlights
Key Capabilities
Key Capabilities
Drug Substance Development & Manufacturing
Drug Substance Development & Manufacturing
Route Scouting, Process R&D & Manufacturing
Process Safety Assessment
Chemistry & Engineering Technologies
Drug Product Development & Manufacturing
Analytical Development & QC
Regulatory Affairs
Teams & Experience
Facilities & Capacity
Quality, EHS, IP
Technology Innovation
Overview & Highlights
Key Capabilities
Key Capabilities
Flow chemistry
Micropacked Bed Technology
Catalysis
Solid State Chemistry
Crystallization
Engineering Technologies
Teams & Experience
Home
About Us
Resources
News & Events
Sites
Discovery
Development & Manufacturing
Technologies
Careers
Contact
Product Website
News & Events
News & Events Menus
News & Events
News
Events
PharmaBlock Awarded "2019 Top 20 CRO in China"
Sep 17,2019
PharmaBlock Participate in Pfizer's QBB Program as a Key Vendor of Building Blocks
Aug 28,2019
PharmaBlock Attended APRDL Shedding Light on CMC Challenges in Drug Development for Expediting New Drug Approvals
Apr 19,2019
PharmaBlock Invests Over 65 Million USD on New Discovery Chemistry and Process R&D Center
Dec 21,2018
PharmaBlock Begins Operation of New Process R&D Center in Pennsylvania
Nov 26,2018
PharmaBlock Acquires a GMP compliant Manufacturing Facility to Support Ongoing Customer Demand
Sep 28,2018
PharmaBlock appoints Dr. Shijie Zhang as Chief Technology Officer
Sep 20,2018
Dr. Michael Jay Shapiro, Senior Consultant and Vice President of PharmaBlock, has been awarded member of "Nanjing Science &Technology Leading Expert Gathering Program"
Jul 02,2018
FDA Grants Approval of TIBSOVO®, the First Oral, Targeted Therapy for Adult Patients with Relapsed/Refractory Acute Myeloid Leukemia and an IH1 Mutation
Jul 23,2018
PharmaBlock Attended APRDL 2018 on Invitation to Deliver a Keynote Speech
Apr 20,2018
1
2
3
4
5
6